ITI Pharma and Healthcare Fund · Regular · Growth
NAV
₹18.0807
as of 29 Sept 2026
Expense Ratio
2.62%
AUM
₹234 Cr
Lumpsum returns (CAGR)
- 1Y
- +14.37%
- 3Y
- +17.67%
- 5Y
- —
- Since Inception
- +12.88%
SIP returns (XIRR)
- 1Y
- +20.98%
- 3Y
- +12.89%
- 5Y
- —
- Since Inception
- +15.87%
What history actually did — last 4 years (Sept 2022 – Sept 2026)
A ₹5,000 monthly SIP for the last 4 years (Sept 2022 – Sept 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹3,26,552 today — ₹2,40,000 invested, 15.7% XIRR.
₹2,40,000
Invested
₹3,26,552
Value today
15.7%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 4 years (Sept 2022 – Sept 2026)
Real NAV backtest
₹1,00,000 invested 4 years ago would be ₹1,92,619 today (17.8% CAGR).
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹3,26,552 in this fund vs ₹2,74,671 in the benchmark — outperformance of ₹51,881.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 4 years (Sept 2022 – Sept 2026) (3 Jun 2024) would be ₹1,36,275 today (1.36×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.55
Sharpe Ratio
+0.10
Alpha
0.20
Beta
0.55
Sortino
13.20%
Std Dev
-14.24%
Max Drawdown
Performance Comparison
Thinking about ITI Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
What this fund does
ITI Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ITI Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by ITI Mutual Fund. The fund has been operational for over 4 years. It manages assets worth ₹234 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.62%.